CLINICAL TRIALS PROFILE FOR GRALISE

All Clinical Trials for GRALISE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01067144 ↗	Stanford Accelerated Recovery Trial (START)	Terminated	Stanford University	Phase 3	2010-05-01	The goal of this study is to determine whether administering Gabapentin prior to surgery affects duration of pain and opioid use post-surgery. The investigators aim to compare gabapentin to placebo in a prospective, randomized clinical trial in which patients will be followed post-surgery until pain resolves and opioid use ceases.
NCT01301001 ↗	A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response	Completed	University of Tennessee Health Science Center	N/A	2012-08-01	The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options.
NCT01301001 ↗	A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response	Completed	University of Tennessee	N/A	2012-08-01	The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options.
NCT01533753 ↗	Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer	Terminated	University of Wisconsin, Madison	Phase 2	2012-02-01	The purpose of this study is to assess the change in quality of life over a 6 month period between gabapentin and venlafaxine in men with prostate cancer treated for hot flashes related to androgen deprivation therapy.
NCT01623271 ↗	Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)	Terminated	Massachusetts General Hospital	N/A	2013-05-01	The purpose of this study is to see if an FDA-approved drug (Gralise) can help people with certain types of neuropathic pain without causing too many side effects.

Clinical Trial Conditions for GRALISE

Condition Name

Condition Name for GRALISE
Intervention	Trials
Pain	3
Post-laminectomy Pain Syndrome	1
Acute Pain	1
Ulcerative Colitis	1

Condition MeSH

Condition MeSH for GRALISE
Intervention	Trials
Head and Neck Neoplasms	4
Squamous Cell Carcinoma of Head and Neck	2
Pain, Postoperative	2
Syndrome	2

Clinical Trial Locations for GRALISE

Trials by Country

Trials by Country for GRALISE
Location	Trials
United States	18
Lebanon	1

Trials by US State

Trials by US State for GRALISE
Location	Trials
New York	4
Illinois	2
Massachusetts	2
Tennessee	2
California	2

Clinical Trial Progress for GRALISE

Clinical Trial Phase

Clinical Trial Phase for GRALISE
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	4
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for GRALISE
Clinical Trial Phase	Trials
Completed	9
Terminated	6
Unknown status	2

Clinical Trial Sponsors for GRALISE

Sponsor Name

Sponsor Name for GRALISE
Sponsor	Trials
National Cancer Institute (NCI)	4
Depomed	2
Massachusetts General Hospital	2

Sponsor Type

Sponsor Type for GRALISE
Sponsor	Trials
Other	20
NIH	4
Industry	2